Latest Ascelia Pharma News & Updates

See the latest news and media coverage for Ascelia Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ascelia Pharma

Biotech company focused on orphan oncology drugs

ascelia.com

Headquarters: Malmö, Sweden
Founded year: 2000
Company type: Public company
Number of employees: 10–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Ascelia Pharma

In short: Ascelia Pharma completed an FDA Type A meeting to discuss the Complete Response Letter for its Orviglance New Drug Application.

Company announcements

September 10 Ascelia Pharma

Ascelia Pharma conducted FDA meeting on Orviglance NDA

The company discussed the Complete Response Letter with the authority and expects the meeting minutes within approximately 30 days.

August 18 Ascelia Pharma

Ascelia Pharma announces Q2 earnings call

CEO Magnus Corfitzen presents results on August 21 at 10:00 via virtual live event for investors to answer questions.

August 17 Ascelia Pharma

Ascelia Pharma schedules FDA Type A meeting for Orviglance NDA discussion

The meeting will address the Complete Response Letter received on July 2 regarding the New Drug Application. Ascelia prepared a detailed briefing package covering clinical and quality data.

July 15 Ascelia Pharma

Ascelia Pharma announces organizational changes and reduced cost base

CFO Anton Hansson leaves the company, focus on FDA meeting for Orviglance.

Media coverage

September 10 Yahoo Finance

Ascelia Pharma Completes FDA Type A Meeting on Orviglance NDA

MALMÖ, SE / ACCESS Newswire / September 10, 2026 / (STO:ACE) completed the previously scheduled Type A meeting with the U. Food and Drug Administration...

August 20 Investing.com

Ascelia Pharma limits Q2 loss while FDA setback presses shares

Risk warning: Trading in financial instruments and/or cryptocurrencies involves a high risk, such as the possibility that you lose all or part of the...

August 19 ZoneBourse

Ascelia Pharma AB (publ) publishes its results for the second quarter and the first half ended June 30, 2026

Ascelia Pharma AB has communicated its financial results for the second quarter and the first half ended June 30, 2026. For the second quarter...

August 19 Økonomisk Ugebrev

Ascelia Pharma: Investors fumble in the dark until FDA meeting minutes

It was the worst possible outcome for Ascelia Pharma and its investors, when the FDA over the summer gave a negative answer to the application...

Never miss news about Ascelia Pharma

Track Ascelia Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ascelia Pharma competitors & trending companies

Browse news for competitors to Ascelia Pharma and other trending companies.